Serkan Duman

Serkan Duman

Auto-generated profile, based on publicly available information

Serkan Duman

Department of Gastroenterology, Toros State Hospital, Mersin, Turkiye

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2023 in European Radiology
Verified
Journal Article
Closed access
PDF file
SDSerkan Duman
Serkan Duman
DKDigdem Kuru
Digdem Kuru
MGMesut Gumussoy
Mesut Gumussoy
SKSaba Kiremitci
Saba Kiremitci
HGHale Gokcan
Hale Gokcan
RIRamazan Idilman
Ramazan Idilman

15 August 2024 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
MÖMübin Özercan
Mübin Özercan
ZEZeynep Melekoğlu Ellik
Zeynep Melekoğlu Ellik
APAyhan Parmaksız
Ayhan Parmaksız
MGMesut Gümüşsoy
Mesut Gümüşsoy
SDSerkan Duman
Serkan Duman
NÖNecati Örmeci
Necati Örmeci
Background/Aims: The presence of liver fibrosis is the most important indicator of progression to cirrhosis. Noninvasive measurement of liver stiffness is crucial for detecting fibrosis. Vibration-controlled transient elastography is one of the most useful methods for this purpose. We aimed to compare the liver stiffness and steatosis measurements with iLivTouch© and the FibroScan© elastography devices Materials and Methods: Two hundred thirty-seven consecutive adult patients with chronic hepatitis were included in the study. The liver stiffness and steatosis were measured with iLivTouch and FibroScan on the same day. Thirty-one patients had liver biopsies on the same day with elastography procedures. The diagnostic performances of iLivTouch and FibroScan were compared to aspartate aminotransferase to platelet ratio index (APRI), Fibrosis-4 (FIB-4), and nonalcoholic fatty liver disease fibrosis score (NFS). Results: The liver stiffness measurements obtained using iLivTouch and FibroScan had median value of 10.3 (ranging from 2.9 to 46.3) and 7.2 (ranging from 2.5 to 75), respectively. The mean steatosis measurements using ultrasound attenuation parameter with iLivTouch were 245.51 ± 45.79, while the mean controlled attenuation parameter measurements using FibroScan were 259.37 ± 75.0. In subgroup analysis, the AUC of iLivTouch on detecting signiicant fibrosis [0.83, (P = .002)] was minimally higher than other noninvasive methods [0.82 for NFS (P = .003), 0.80 for FibroScan (P = .006), 0.68 for FIB-4 (P = .089), and 0.53 for APRI (P = .76)]. Conclusion: The stiffness and steatosis measurements with iLivTouch and FibroScan were not similar. The accuracy of iLivTouch in detecting significant and advanced fibrosis was minimally higher. Large clinical trials are necessary to support these findings. Cite this article as: Özercan M, Melekoğlu Ellik Z, Parmaksız A, Gümüşsoy M, Duman S, Örmeci N. Liver stiffness and steatosis measurements with iLivTouch and FibroScan: A comparative study. Turk J Gastroenterol. 2024;35(8):634-642.

22 June 2023 in Journal of Digestive Endoscopy
Verified
Journal Article
Open access
PDF file
SDSerkan Duman
Serkan Duman
AYAlper Yurci
Alper Yurci
JCJoo Young Cho
Joo Young Cho
Introduction Primary achalasia is an idiopathic motility disorder of the esophagus characterized by esophageal aperistalsis and incomplete relaxation of the lower esophageal sphincter (LES) in response to swallowing. The gold standard diagnostic method in adults is high-resolution manometry (HRM). Diagnostic criteria in adults are also used in children, but some HRM normal values may change depending on age. Case Report A 15-month-old girl was admitted to the hospital for evaluation due to persistent vomiting since birth. Vomiting included what she ate regardless of the amount of food she consumed. Barium esophagography revealed barium retention, esophageal dilatation, and a “bird's beak appearance” in the distal esophagus. Esophagogastroduodenoscopy revealed stenosis in the lower esophagus and bubbles at the esophagogastric junction.In HRM, the resting LES pressure was 43.4 mm Hg, there was pan-esophageal pressurization with 60% of swallows and no normal peristalsis. The patient was diagnosed with type II achalasia based on the Chicago 3.0 classification.First, the tube was inserted to ensure adequate nutrition of the patient, and approximately 4 months later, when the patient was 10 kg, the peroral endoscopic myotomy (POEM) procedure was performed.No complications developed during and after the procedure. At the 6th month after treatment, the patient was completely asymptomatic and her weight was within normal limits for her age. Conclusion POEM is an effective and safe method in the treatment of pediatric patients with idiopathic achalasia.

15 December 2022 in Turkish Journal of Gastroenterology
Verified
Journal Article
Closed access
RERamazan Erdem Er
Ramazan Erdem Er
SDSerkan Duman
Serkan Duman
EBEmin Bodakçı
Emin Bodakçı
BYBüşra Yarcı
Büşra Yarcı
ASArif İrFan Soykan
Arif İrFan Soykan
MTMurat Toruner
Murat Toruner
Background: Coronavirus disease-2019 has become a serious pandemic, and still remains a risk despite vaccines that have been devel- oped. Among inflammatory bowel disease patients old age, inflammatory bowel disease activation, the existence of the comorbid dis- ease, and using steroids are known risk factors for severe coronavirus disease-2019. But there are different data for drugs other than corticosteroids used. The aims of the study are to evaluate the prevalence and risk factors of severe coronavirus disease-2019 and the effect of inflammatory bowel disease drugs on severe coronavirus disease-2019. Methods: In this study among 1195 inflammatory bowel disease patients, 130 patients who were found to be positive for severe acute respiratory syndrome coronavirus-2 between March 2020 and May 2021 were evaluated. Patients were divided into 3 groups as mild, moderate, and severe coronavirus disease-2019. Results: Among 130 patients, 91 (70%) had mild, 16 (12.3%) had moderate, and 23 (17.7%) had severe coronavirus disease-2019. Being 60 years of age or older (P = .009), having at least 1 comorbid disease (P = .002), and having active inflammatory bowel disease (P = .001) were factors that increased the risk for severe coronavirus disease-2019. The use of mesalazine (P = .35), biologic agents (P = .23), and corticosteroids (P = .42) did not increase the risk of severe coronavirus disease-2019. The use of azathioprine seemed to decrease the risk of severe disease with univariate regression analysis however the significance disappeared with multivariate analysis. Conclusion: Older age, active inflammatory bowel disease, and existence of at least 1 comorbid disease are risk factors for severe coro- navirus disease-2019. However, drugs used in inflammatory bowel disease management do not increase the risk of severe coronavirus disease-2019. But due to the small number of patients, it is difficult to reach a definite conclusion about corticosteroids. Cite this article as: Er RE, Duman S, Bodakçı E, Yarcı B, Soykan İ, Törüner M. The impact of inflammatory bowel diseases and related medications on COVID-19 severity and outcome: A tertiary referral center experience from turkey. Turk J Gastroenterol. 2022;33(12):1025-1032.

17 September 2025
Verified
Book
Open access
PDF file
AMAlper Macif
Alper Macif
ABAhmed Ramiz Baykan
Ahmed Ramiz Baykan
GÇGökhan Çoban
Gökhan Çoban
SYSadik Yavuz
Sadik Yavuz
BBBas Bas
Bas Bas
BBBüşra Başkan
Büşra Başkan
1

17 September 2025
Verified
Book Chapter
Open access
PDF file
SDSerkan Duman
Serkan Duman
OSOzan Fatih Sarıkaya
Ozan Fatih Sarıkaya
Endoskopik işlemler sırasında antitrombotik ilaçların yönetimi kanama ve tromboz riskinin dikkatli bir şekilde dengelenmesini gerektirir. Antiplatelet ve antikoagülan ilaçlar kesilirken ve tekrar başlanırken, kullanılan ilaçların özellikleri, işlem sırasında yeterli hemostaz sağlanıp sağlanmadığı, endoskopik müdahalenin gecikmiş kanama riski, hastanın tromboz riski, hastanın tercihleri göz önünde bulundurulmalıdır.